FOXO1 Content Is Reduced in Cystic Fibrosis and Increases with IGF-I Treatment
AbstractCystic fibrosis-related diabetes is to date the most frequent complication in cystic fibrosis (CF). The mechanisms underlying this condition are not well understood, and a possible role of insulin resistance is debated. We investigated insulin signal transduction in CF. Total insulin receptor, IRS1, p85 PI3K, and AKT contents were substantially normal in CF cells (CFBE41o-), whereas winged helix forkhead (FOX)O1 contents were reduced both in baseline conditions and after insulin stimulation. In addition, CF cells showed increased ERK1/2, and reduced β2 arrestin contents. No significant change in SOCS2 was observed. By using a CFTR inhibitor and siRNA, changes in FOXO1 were related to CFTR loss of function. In a CF-affected mouse model, FOXO1 content was reduced in the muscle while no significant difference was observed in liver and adipose tissue compared with wild-type. Insulin-like growth factor 1 (IGF-I) increased FOXO1 content in vitro and in vivo in muscle and adipose tissue. In conclusion; we present the first description of reduced FOXO1 content in CF, which is compatible with reduced gluconeogenesis and increased adipogenesis, both features of insulin insensitivity. IGF-I treatment was effective in increasing FOXO1, thereby suggesting that it could be considered as a potential treatment in CF patients possibly to prevent and treat cystic fibrosis-related diabetes. View Full-Text
- Supplementary File 1:
Supplementary Information (PDF, 570 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Smerieri, A.; Montanini, L.; Maiuri, L.; Bernasconi, S.; Street, M.E. FOXO1 Content Is Reduced in Cystic Fibrosis and Increases with IGF-I Treatment. Int. J. Mol. Sci. 2014, 15, 18000-18022.
Smerieri A, Montanini L, Maiuri L, Bernasconi S, Street ME. FOXO1 Content Is Reduced in Cystic Fibrosis and Increases with IGF-I Treatment. International Journal of Molecular Sciences. 2014; 15(10):18000-18022.Chicago/Turabian Style
Smerieri, Arianna; Montanini, Luisa; Maiuri, Luigi; Bernasconi, Sergio; Street, Maria E. 2014. "FOXO1 Content Is Reduced in Cystic Fibrosis and Increases with IGF-I Treatment." Int. J. Mol. Sci. 15, no. 10: 18000-18022.